Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA
Kristina Pagh Friis(AstraZeneca (Sweden)), Annette Bak(AstraZeneca (United States)), Johnny Lindqvist(AstraZeneca (Sweden)), Steven Oag(AstraZeneca (Sweden)), Botilda Lindberg, Sandra Gracin(AstraZeneca (Sweden)), Elisa Lázaro‐Ibáñez(AstraZeneca (Sweden)), Alexandra Leijon(AstraZeneca (Sweden)), Elin Sand(AstraZeneca (Sweden)), Kathryn A. Whitehead(Carnegie Mellon University)
Cited by 61
Related Papers
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
|Nature Reviews Drug Discovery|2021|1.5k
Selection of Fluorescent, Bioluminescent, and Radioactive Tracers to Accurately Reflect Extracellular Vesicle Biodistribution <i>in Vivo</i>
|ACS Nano|2021|263
Extracellular vesicles and intercellular communication within the nervous system
|Journal of Clinical Investigation|2016|261
Quantification of protein cargo loading into engineered extracellular vesicles at single‐vesicle and single‐molecule resolution
|Journal of Extracellular Vesicles|2021|192